Rp. Verkooyen et al., DIAGNOSIS OF CHLAMYDIA-PNEUMONIAE INFECTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE BY MICRO-IMMUNOFLUORESCENCE AND ELISA, Journal of Medical Microbiology, 46(11), 1997, pp. 959-964
The incidence of Chlamydia pneumoniae infection was determined in pati
ents with chronic obstructive pulmonary diseases (COPD) by prospective
serial serology. Chlamydia-specific IgG, IgM and IgA antibodies were
detected with a recombinant DNA lipopolysaccharide (LPS) ELISA as well
as with a micro-immunofluorescence (MIF) assay with C. pneumoniae ele
mentary bodies, From 271 consecutive COPD patients who visited the out
patient clinic of the department of pulmonary diseases (211 males, 60
females, age range 34-88 years, mean age 66 SD 10 years), blood sample
s (n = 1058) were taken every 2-7 months; the observation period range
d from 3 to 19 months (mean 15 SD 4), The prevalence of chlamydial IgG
was 72% with the MIF and 53% with the rDNA LPS ELISA, More than 90% o
f the COPD patients had no significant changes in their chlamydia-spec
ific IgG, IgA and IgM titres in either test during the observation per
iod, Seven (3%) patients had MIF results indicating acute C. pneumonia
e infection during their surveillance period, of whom five were confir
med by rDNA LPS ELISA, Eleven (4%) additional patients were infected d
uring observation, as determined by rDNA LPS ELISA only, These patient
s had significantly elevated C. pneumoniae-specific IgG and IgA MIF ti
tres; as compared with the patients without infection, All 18 patients
with serological evidence of acute infection during their surveillanc
e period were re-tested in a commercial MIF test that can distinguish
between C. pneumoniae, C. trachomatis and C. psittaci LPS-specific ant
ibodies, but no evidence of C. trachomatis or C. psittaci infection wa
s found, The incidence of chlamydial infection was 2.2 and 5.3/100 per
son-years, when diagnosed by MIF and rDNA LPS ELISA, respectively, It
is concluded that the rDNA LPS chlamydia assay may currently be the mo
st sensitive serological tool for diagnosing recent respiratory chlamy
dia infections and that C. pneumoniae infection occurs frequently in C
OPD patients.